For example, estrogens bind directly to INS, inhibiting binding to the INS receptor (IR), which may contribute to the observed variations in INS sensitivity observed during the menstrual cycle and also upon use of estrogen-containing birth control, as well as in gestational diabetes [17]. The gene discussed is INS; the disease is gestational diabetes.